Results 231 to 240 of about 23,670 (299)

Leveraging Large and Diverse Biobanks to Evaluate Gene-Disease Associations in Hypertrophic Cardiomyopathy. [PDF]

J Pers Med
Dababneh SF, Ong K, Yeung D, Hawkins NM, Krahn A, Laksman Z, Tadros R, Roston TM.   +7 more
europepmc   +1 more source

Clinical Relevance of BACH1 Expression in Non–Small Cell Lung Cancer

International Journal of Cancer, EarlyView.
ABSTRACT BTB and CNC homolog 1 (BACH1) is a redox‐sensitive transcription factor implicated in tumor progression, metabolic reprogramming, and therapy resistance in several cancers. However, its prognostic significance and role in therapy resistance in non–small cell lung cancer (NSCLC) remain unclear.
Jing Liu, Marc A. Schneider, Julia Held, Sabine Wrenger, Wenzhang Si, Michael Allgaeuer, Florian Eichhorn, Sabina Janciauskiene   +7 more
wiley   +1 more source

A Genome-First Study of Familial Hypercholesterolemia Comparing African and European Ancestry Individuals. [PDF]

Circulation
Winters AH, Kelly MA, Syed MG, Bergquist T, Berry ASF, Mohammed N, Cawley D, Jones LK, Pejaver V, Gidding SS, Oetjens MT.   +10 more
europepmc   +1 more source

Spatially Resolved Metabolomics of Optimal Cutting Temperature (OCT) Compound‐Embedded Tumors

International Journal of Cancer, EarlyView.
ABSTRACT Mass spectrometry imaging (MSI) is emerging as a powerful tool for uncovering the distribution of metabolites in the tumor microenvironment and studying tumor metabolism in vivo. To date, MSI of biobanked tissues contextualized by patient data has been limited to peptides, proteins, and glycans—with few examples for metabolites.
Joseph Monaghan, Nicholas Woytowich, Tian Zhao, Kiera Nguyen, Emily Mahony, Julian J. Lum, Kyle D. Duncan   +6 more
wiley   +1 more source

The Biobank Rare Variant consortium powers the discovery of rare genetic associations through global collaboration

Palmer DS, Hill B, Hodgson S, Jõeloo M, Kalantzis G, Kousathanas A, Koyama S, Lu W, Namba S, Rodriguez ZB, Shortt JA, Sonehara K, Vartanian N, Vy HMT, Wade IA, White SL, Baya NA, Chami N, Do R, Estrada K, Finer S, Genovese G, Guez J, Itan Y, Kanai M, Lassen FH, Matsuda K, Moutsianas L, Peloso GM, Palta P, Rader DJ, Rendon A, Rocheleau G, Sadeghi-Alavijeh O, Selvaraj MS, Smit RA, Wang D, Wigdor EM, Yu Z, Colorado Center for Personalized Medicine, Estonian Biobank Research Team, Genes & Health Industry Consortium1, Genes & Health Research Team, Penn Medicine BioBank, The BioBank Japan Project, Gignoux CR, Heyne H, Loos RJ, Martin HC, Milani L, Natarajan P, Okada Y, Pozdeyev N, van Heel DA, Verma A, Zhou W, Karczewski KJ, Lindgren CM, Neale BM.   +58 more
europepmc   +1 more source

Genome-wide analysis implicates inner ear development in Ménière disease. [PDF]

Am J Hum Genet
Shi Z, Mandla R, Li J, Li X, Zhang ZE, Chen S, Lapinska S, Flynn-Carroll AO, Pasaniuc B, Epstein DJ, Mathieson I.   +10 more
europepmc   +1 more source

Ethical navigation of biobanking establishment in Ukraine: learning from the experience of developing countries. [PDF]

J Med Ethics
Sulaieva ON, Artamonova O, Dudin O, Semikov R, Urakov D, Zakharash Y, Kacharian A, Strilka V, Mykhalchuk I, Haidamak O, Serdyukova O, Kobyliak N.   +11 more
europepmc   +1 more source

Biobanks for Research

, 2004
National Ethics Council (Germany) / Nationaler Ethikrat
core  

Evidence-based standardization of infectious disease biobanking: aligning specimen preservation and clinical metadata with <i>in vitro</i> diagnostic clinical trials requirements. [PDF]

Front Public Health
Xia C, Liao X, Yang S, Cheng F, Qi M, Ouyang J, Guan B, Chen Y.   +7 more
europepmc   +1 more source

Benefit-sharing and biobanks

, 2007
Simm, Kadri
core